Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.800.890.940.760.60

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 0.80 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.80
Mar20230.89
Mar20220.94
Mar20210.76
Mar20200.60

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.8
-10.11
Mar2023 0.89
-5.32
Mar2022 0.94
23.68
Mar2021 0.76
26.67
Mar2020 0.6 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹18,945.2 Cr -6.1% 0.8% 8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,993.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 2.1% 1.2% -5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-6.1%

0.8%

8.9%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses